Sampaio-Neto José, Nassif Luís Sérgio, Branco-Filho Alcides José, Bolfarini Luciana Alves, Loro Luiara Stefanelo, de Souza Mayara Prudêncio, Bianco Thais
Pontifical Catholic University of Paraná, Curitiba, PR, Brazil.
Arq Bras Cir Dig. 2015;28 Suppl 1(Suppl 1):19-22. doi: 10.1590/S0102-6720201500S100007.
DiaRem score consists in preoperative model for predicting remission of type 2 diabetes mellitus in obese patients who underwent gastric bypass.
To evaluate the applicability of DiaRem comparing the scores obtained preoperatively with remission of T2DM after surgery.
Preoperative parameters such as age, use of insulin, oral hypoglycemic agents and glycated hemoglobin, were retrospectively evaluated in diabetic patients undergoing gastric bypass during the period between July 2012 to July 2013. Through these data the DiaRem score were applied. The results of fasting blood glucose and glycated hemoglobin were requested prospectively.
Were selected 70 patients; the remission of T2DM after surgery was found in 42 (60%) and no remission in 28 (40%). Checking the final score, it was observed that: from 0 to 2 points, 94.1% of patients remitted completely; between 3 and 7 had remission in 68.9%, of which 42.8% complete; from 8 to 12, 57.1% achieved complete remission; between 13 to 17, 87.5% did not achieve remission and was not seen this complete remission group; between 18 to 22, 88.9% were not remitted.
The DiaRem score showed appropriate tool to assess remission of T2DM in obese patients who will undergo gastric bypass.
DiaRem评分是一种术前模型，用于预测接受胃旁路手术的肥胖患者2型糖尿病的缓解情况。
通过比较术前获得的评分与术后2型糖尿病的缓解情况，评估DiaRem评分的适用性。
回顾性评估2012年7月至2013年7月期间接受胃旁路手术的糖尿病患者的术前参数，如年龄、胰岛素使用情况、口服降糖药和糖化血红蛋白。通过这些数据应用DiaRem评分。前瞻性地获取空腹血糖和糖化血红蛋白的结果。
选取70例患者；术后2型糖尿病缓解者42例（60%），未缓解者28例（40%）。检查最终评分发现：0至2分，94.1%的患者完全缓解；3至7分，68.9%的患者缓解，其中42.8%完全缓解；8至12分，57.1%的患者完全缓解；13至17分，87.5%的患者未缓解，且该组未见完全缓解者；18至22分，88.9%的患者未缓解。
DiaRem评分是评估即将接受胃旁路手术的肥胖患者2型糖尿病缓解情况的合适工具。
